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ABSTRACT
Deep sequencing studies frequently identify small
RNA fragments of abundant RNAs. These fragments
are thought to represent degradation products of
their precursors. Using sequencing, computational
analysis, and sensitive northern blot assays, we
show that constitutively expressed non-coding
RNAs such as tRNAs, snoRNAs, rRNAs and
snRNAs preferentially produce small 50 and 30 end
fragments. Similar to that of microRNA processing,
these terminal fragments are generated in an asym-
metric manner that predominantly favors either the
50 or 30 end. Terminal-specific and asymmetric pro-
cessing of these small RNAs occurs in both mouse
and human cells. In addition to the known process-
ing of some 30 terminal tRNA-derived fragments
(tRFs) by the RNase III endonuclease Dicer, we
show that several RNase family members can
produce tRFs, including Angiogenin that cleaves
the TtC loop to generate 30 tRFs. The 30 terminal
tRFs but not the 50 tRFs are highly complementary
to human endogenous retroviral sequences in the
genome. Despite their independence from Dicer
processing, these tRFs associate with Ago2 and
are capable of down regulating target genes by
transcript cleavage in vitro. We suggest that en-
dogenous 30 tRFs have a role in regulating the un-
warranted expression of endogenous viruses
through the RNA interference pathway.
INTRODUCTION
Recent applications of deep sequencing methods have led
to the identiﬁcation of a surprising diversity of non-
protein-coding RNAs (ncRNAs), including degradation-
like small RNA fragments derived from miRNAs (1,2),
snoRNAs (3–5) and tRNAs (6–12). Evidence is
accumulating that these small RNA fragments are pre-
cisely processed to participate in diverse biological
processes and are conserved in distantly related species
(2,3,5–7,13). The ﬁrst report of a small snoRNA-derived
RNA and its function as a miRNA was reported 3 years
ago (3). Since then, 10 additional snoRNA-derived small
(18 nt) RNAs that can function as miRNAs have been
described (5). We have also reported a group of human
and viral unusually small (15 nt) RNAs (usRNAs)
that are derived from miRNAs as well as other
non-coding regions, and can regulate gene (e.g., RAD21)
expression (2). Production of these usRNAs are evolution-
arily conserved (13,14) and are associated with
hippocampal functions in mice (13).
It is common to ﬁnd small RNA fragments that match
long RNA transcripts such as mRNAs in small RNA
sequencing data (8). The presence of such small RNA frag-
ments is generally attributed to the extreme sensitivity of
deep sequencers in detecting low-abundance RNAs
including degradation products. However, even very low-
abundanceRNAs, as low as four copies per cell, originating
from theCyclinD1 (CCND1) promoter region are reported
to have regulatory functions (15). While many of the RNA
fragments in deep-sequencing data frequently correspond
to low abundance, potentially non-functional RNA
products, RNA fragments found at even greater abundance
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than most miRNAs are also frequently observed in small
RNA sequencing data (2,7). Common sources for such
RNA fragments are tRNAs and rRNAs. Since tRNAs
and rRNAs constitute most of the cellular RNA, it is rea-
sonable to assume that these RNAs generate much more
degradation products than other RNAs, resulting in the
preferential detection of their degradation products in
deep-sequencing. While the notion of degradation
products is appealing, it was recently shown that tRNAs
and rRNAs undergo stress-induced cleavage to produce
stable RNA products, and this mechanism is conserved
from yeast to human cells (11). In human cells, tRNA frag-
ments have been reported to induce transient translational
arrest (12). Various tRNA fragments are produced in cells
under stress; notably during starvation in Tetrahymena
thermophila (9) and serum deprivation in Giardia lambia
(10), or during development in Aspergillus fumigatus (16).
Stress-induced tRNA cleavage is mediated by Rny1p in
yeast (17) and angiogenin (ANG) in humans (12,18).
These stress-induced tRNA cleavage products are
30–50 nt in length and seem to form related RNA classes,
termed sitRNA (10), tiRNA (12,19) and tRNA halves
(11,16,18). An additional class of small RNAs that are
2030 nt long, and are derived from 50 or 30 ends of
tRNAs or from the genomic region following the 30 end
of tRNAs, broadly termed tRNA fragments (tRFs) were
also reported (7). Subsequently, another class of seemingly
related tRNA-derived small RNAs (tsRNAs) was found to
function similarly to miRNAs. These tsRNAs are
processed by either Dicer or RNase Z, depending on the
tRF locations within both the mature tRNAs and their
precursors (6). In summary, the widespread occurrence of
stable small RNAs and their emerging roles in cellular
processes indicate that we cannot ignore such molecules
as randomly generated degradation products. Systematic
analysis of all sequence reads from deep sequencing data
may prove useful in deﬁning new biological features and
mechanisms relating to both canonical and non-canonical
forms of small RNAs.
In this study, we found that the majority of the 20 nt
long fragments deriving from the mature sequences of the
widely expressed tRNAs, rRNAs, snoRNAs and snRNAs,
but notmRNAs, are produced in a speciﬁc cleavage pattern
from the 50 or 30 ends. We note that this pattern was previ-
ously observed for snoRNAs (3–5), and tRNAs (6–8).
Similar to the processing of miRNAs, these terminal
RNAs accumulate in the cell in an asymmetric manner
that favors the expression of either the 50 or the 30 end frag-
ments. The terminal fragments, are largely independent of
canonical RNA interference (RNAi) processing
machineries, which include Dicer that processes precursor
miRNAs (pre-miRNAs), and DGCR8, which partners
with Drosha to form the microprocessor complex that
processes primary miRNA transcripts to pre-miRNAs.
The biogenesis of tRFs is likely to depend on multiple
RNase family members, including ANG that cleaves
tRNAs within the TcC loop in a sequence-speciﬁc
manner. Notably, antisense sequences of 30-terminal tRFs
are highly enriched in genomic regions harboring retroviral
sequences, and 30 tRFs are found to cleave target RNA
through endogenous association with Ago2.
MATERIALS AND METHODS
Small RNA sequence analysis
Small RNAs reads from the B lymphoma BCP1 cell line
were processed and mapped to the transcriptome as
reported earlier (2). Small RNA sequences from mouse
embryonic stem cells and HEK293 cells were retrieved
from NCBI (GSE 12521 and GSE 16579). A total of 522
tRNA genes were curated from gtRNAdb (20), excluding
109 predicted pseudo tRNA genes. Perfect matches
between reads and tRNAs were imposed to obtain the
most reliable list of tRNA-derived RNAs. To eliminate
any bias in our analysis due to terminal CCA motifs
that are known to occur in tRNAs, the terminal CCA of
tRNAs were masked. For comparison of the abundance of
miRNA and different classes of terminal RNA in Dicer or
DGCR8 knockout libraries, reads from different libraries
were normalized using the total number of mRNA
fragments in each library. For normalization, the total
number of mRNA fragments (15 nt) in each library
was used to ﬁrst divide the read counts of each distinct
RNA in that library, and then scaled by multiplying by the
total number of mRNA reads in the reference (wild-type)
library. To focus on the most reproducible set of tRFs, a
threshold of 10 reads/million was used for the analysis of
tRFs (Figures 3A, 4B, C and 8B; Supplementary
Figure S5).
To detect putative tRNA orthologs, we identiﬁed 137
human and mouse tRNA pairs with signiﬁcantly high
similarity (>80%) over >90% of the tRNA sequences.
For analysis of retrotransposons, coordinates for human
LTR, LINE and SINE elements were downloaded from
UCSC genome database (21). To be considered as a
potential tRF binding site, we required perfect match of
the antisense sequence to the LTR, LINE and SINE
elements. To eliminate artifacts due to the different sizes
of LTR, LINE and SINE regions, the number of putative
binding sites was normalized with respect to the total
length of each of those elements. Since the length of the
regions spanned by LINE and SINE elements were larger
than LTR elements, the appropriate normalization factors
of 0.42 and 0.67 were used to multiply the number of
binding sites in LINE and SINE elements, respectively.
All tRF sequences identiﬁed in BCP1 and were at least
10 nt long were used for the analysis. Since tRNAs can
share similar terminal sequences, the terminal sequences
that match to the most anti-LTR tRFs were selected as
representative regions for illustrations.
Northern blot analysis
Northern blots were based on our recently published
protocol (22). Brieﬂy, total RNA (10–50mg) was separated
on 18% denaturing polyacrylamide gels and electro-
transferred to positively charged nylon membranes from
Roche (Roche Applied Science, Indianapolis, IN, USA).
LNA–DNAmixed oligonucleotide probes were synthesized
by IDT (Integrated DNA Technologies, Inc. Coralville, IA,
USA). Probes were labeled with the small molecule
Digoxigenin (DIG) using Oligo End Tailing Kit (Roche
Applied Science, Indianapolis, IN, USA). Hybridization
6788 Nucleic Acids Research, 2012, Vol. 40, No. 14
was carried out overnight in Ultrahyb buffer (Ambion,
Austin, TX, USA) at 42C and washing was performed in
two rounds of 0.1SSC/0.1%SDS at 60C. DIG signals
were detected with alkaline phosphatase-conjugated
anti-DIG antibody (Cat. 11093274910, Roche). Probes
used for northern blotting corresponds to (LNAs in bold):
30 end tRF of tRNALysTTT (50-TGGCGCCCGAACAGG
A-30); 50 end tRF of tRNALysTTT (50-CTGAGCTATCCG
GGAA-30); 30 end tRFof tRNAPheGAA (50-GTGCCGAA
ACCCG-30); 50 end tRF of tRNA PheGAA (CTCCCA
ACTGAGCTATTTCG); miR-17 control RNA (50-CTAC
CTGCACTGTAAGCACTTTG-30), 5.8S rRNA (50-TGAT
CCACCGCTAAGAGT-30); U6 snRNA (50-ATATGGAA
CGCTTCACGAATT-30).
For Ago2-association studies, immunoprecipitated
RNA and 5mg total RNA isolated from HEK293 cells
using Trifast (Peqlab) was separated by 12% denaturing
RNA PAGE and transferred to a nylon membrane (GE
Healthcare) by semidry electroblotting. Membranes were
cross-linked by 1-ethyl-3-(3-dimethylaminopropyl) carbodii-
mide (EDC) chemical crosslink incubating for 1 h at 50C
and hybridized overnight at 50C with the following probes
50-TGGTGCCGTGACTCGGA-30 (tRNAHisGTG), 50-AT
GGTGTCAGGAGTGGGA-30 (tRNA LeuCAG) and
50-TCACAAGTTAGGGTCTCAGGGA complementary
to miR-125b.
In vitro cleavage assay
Recombinant human ANG (Sigma-Aldrich) was dissolved
and diluted to a ﬁnal concentration of 10 mg/ml in 30mM
HEPES, 30mM NaCl and 0.01% BSA. The working
buffer in absence of ANG was used as the control
buffer. RNase A was purchased from Qiagen (Valencia,
CA, USA). RNase I and RNase T1 were purchased from
Ambion (Carlsbad, CA, USA). Incubations of total RNA
were carried out at 37C for 0, 1, 2 and 4 h. Incubations of
in vitro transcribed RNA were carried out at 37C for
0.5 h. The incubation was stopped by adding Trizol
(Invitrogen) into the reaction mixture from which RNA
was extracted. To help with RNA precipitation, 20 mg
glycogen (Life Technologies, Carlsbad, CA, USA) was
added to each sample.
Ago immunoprecipitation and cleavage assay
The construction of human FLAG/HA-Ago1 and FLAG/
HA-Ago2, was reported earlier (23). For RNA cleavage
assay, a synthetic transcript was generated based PCR
ampliﬁcation and in vitro transcription (T7 RNA polymer-
ase, Fermentas). Primers used were: 50-TAATACGACTC
ACTATAGAACAATTGCTTTTACAG-30 (T7 primer),
50-ATTTAGGTGACACTA TAGGCATAAAGAATTG
AAGA-30 (SP6 primer). Target sequences were 50-GAAC
AATTGCTTTTACAGATGCACATATCGAGGTGA
ACATCACGTACGTGGTGCCGTGACTCGGATCG







the sequence complementary to the oligonucleotide with
the speciﬁc cleavage sequence. PCR products were
puriﬁed on denaturing RNA–PAGE followed by etha-
nol precipitation. For RISC activity assays, substrates
were 32P-cap labeled as follows: 1.5 ml (a-32P)-GTP
(3000Ci/mmol), 2 ml 10 buffer (0.4M Tris pH 8.0,
60mM MgCl2, 100mM DTT, 20mM spermidine), 0.25ml
RNasin (Promega), 1 ml S-adenosyl-Met (500mM), 1 ml
DTT (1M), 1 ml Guanyltransferase and RNA from
in vitro transcription reaction was incubated for 3 h at
37C. RNA was puriﬁed by denaturing RNA–PAGE and
recovered by ethanol precipitation. Ago complex-
containing anti-FLAG beads were incubated in a reaction
containing 5 nM target RNA, 1mM ATP, 0.2mM GTP,
10U/ml RNasin (Promega), 100mM KCl, 1.5mM MgCl2
and 0.5mM DTT for 1.5 h at 30C. The reaction was
stopped by proteinase K treatment and RNA was isolated
by phenol/chloroform extraction and ethanol precipitation.
Cleavage products were analysed by denaturing RNA–
PAGE followed by autoradiography using BioMax MS
ﬁlm (Kodak) and an intensifying screen (Kodak).
Production of wild-type and mutated tRNA molecules
To ensure minimum structural disruptions in mutated
tRNA (LysTTT) sequences, the RNAs were folded by
Vienna RNA Package (24), and then manually inspected
using VARNA (25). Wild-type and mutated tRNA se-
quences were constructed using mirVana miRNA Probe
Construction kit (Ambion, Austin, TX, USA). Brieﬂy,
wild-type or mutated tRNA DNA oligos were synthesized
(IDT, IA, USA) and annealed to a shorter DNA oligo
harboring T7 promoter sequence. The partial double-
stranded DNA was ﬁlled in by Klenow polymerase and
then subjected to in vitro transcription by T7 RNA poly-
merase. Synthesized RNA was puriﬁed by Trizol
(Invitrogen), before performing in vitro cleavage assays.
RESULTS
Constitutive ncRNAs but not mRNAs generate
termini-speciﬁc RNAs
We previously reported on 15 nt long unusually small
RNAs (usRNAs) and their sub-groups (2), consisting of
30 end-speciﬁc motifs in human and viral genomes. Two
of these usRNA subgroups share a CCA element in their
30 end. To further study RNAs with the terminal CCA
motif, we reanalyzed 307 269 RNA sequence reads
(1030 nt) that were identiﬁed in the human
KSHV-infected primary-effusion lymphoma cell line,
BCP1 (26). The CCA motif occurs precisely at the 30 end
in 24 601 reads (4482 distinct sequences, Figure 1A).
Terminal, 30-speciﬁc CCA motifs are known to occur in
almost all mature tRNAs (70100 nt), which act as sites
for amino acid residue attachment and as stabilizers for
tRNA-ribosome interactions (27). Since the majority
(85.6%) of reads containing terminal CCA motifs con-
sisted of usRNAs or even smaller RNAs that have not
been the focus of previous studies (6,7,10–12,16,18,19),
we sought to fully characterize the spectra of 1030
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base long terminal CCA-containing RNAs. To reduce
artifacts from short length reads, the analysis was
limited to those reads that perfectly matched tRNA
ends. More than half (13 579 of 24 601 reads) of the
terminal CCA-containing small RNAs matched tRNAs.
We next tested whether tRNAs produce other 1030 nt
long RNAs at other positions in tRNAs in an unbiased
manner as expected for a degradation process involving
random exo/endo-nuclease cleavage. The majority of tRFs
precisely match 50 or 30 ends of tRNAs (Figure 1B and C)
and these 50–30 terminal tRFs matches to 76% (447/522) of
human tRNAs. We ﬁnd a signiﬁcantly higher proportion
of tRFs reads (76%) than previously reported (7) for tRFs
(55%), likely because gel-based isolation of RNAs
>10 nt seem to be necessary to retain the full spectrum
of usRNAs (2). Interestingly, 50 and 30 tRFs display
different size distributions (Figure 1D). The size range of
50 terminal tRFs peaks at 14 and 15 nt, which corresponds
to a smaller size estimate than the previous report of
1819 nt (7); this difference may be due to our inclusion
of a broader range (1030 nt) of RNA fragments, or is
a result of differences between the cell lines in the two
studies.
We next examined if other classes of RNAs also generate
termini-speciﬁc small RNAs. The phenomenon of 50–30-
speciﬁc processing is observed across all major classes of
ncRNAs but notmRNAs (Figure 2). Terminal tRFs are the
most abundant fragments found in deep sequencing,
followed by rRNA-derived RNAs (Supplementary
Figure S1; Figure 1B and C). All ncRNAs generate both
50 and 30 products except snRNAs, which produce small
RNAs exclusively from their 30 termini. We note that
50 modiﬁcations on mRNAs and snRNAs (28) hinder the
cloning of 50 fragments, which might be the most plausible
reason for the absence of 50 snRNA-derived reads in deep
sequencing data. However, despite the large number of
mRNAs, very few mRNA-derived fragments are detected
at 50–30 ends and the proportion of mRNA-derived
fragments across all mRNAs is negligible (Figure 2) sug-
gesting that the processing ofmRNAs into stable fragments
is not a common phenomenon. In comparison to
tRNA-derived tRFs with a read number density of 1.0
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Figure 1. Characteristics of small RNAs (sRNAs) matching to 50 and 30 termini of tRNAs. All positions are determined with respect to either the
50 or 30 ends of sRNAs/tRNAs. To determine the positions, the sRNAs (violet) and tRNAs (blue) are aligned by their 50–30 ends, as noted by
respective illustrations. (A) The CCA motif preferentially occurs at the 30 termini (position 1) of the sRNAs. To avoid artifacts from single
sequences with high number of reads, only distinct sequences that contain CCA were used for the analysis. (B) The visualization of positions of all
reads that map to tRNAs indicates that 30 terminal of tRNAs produce the most number of fragments (30 terminal peak). The two prominent peaks at
60 and 70 nt are due to 50 speciﬁc processing of tRNAs that are 60 and 70 nt long, as illustrated in panel C. (C) Similar to tRNA 30 speciﬁc
reads, 50 terminal of tRNAs are also speciﬁcally processed to yield RNA fragments (50 terminal peak). The tRNA position (with respect to its 50 end)
at which the 50 end of the sRNA reads are matched are used, as depicted by the bottom illustration. (D) Length distribution of 50 (black) and
30 (white) terminal RNAs from tRNAs indicate that 50 terminal RNAs are predominantly 1415 nt long, while 30 terminal RNAs seem to manifest a
broader range (1618 nt).
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read per base, mRNAs yield a noticeably low read density
of 0.0005. Furthermore, there were no reads with purely
poly(A) tails of at least 15 nt long sequences, suggesting
that end processing of mRNAs is a rare event. Although
termini-speciﬁc stable fragments of mRNAs are not
detected in our analysis, it is important to note that very
low abundance (1 copy/10 cells) short RNAs also occur
near transcription start sites ofmRNAs (29,30). These tran-
scription start site-associated (29) RNAs (TSSa-RNAs) or
transcription initiation (30) RNAs (tiRNAs) are distinct
from termini-speciﬁc RNA fragments, because they map
to a wide range of up/down-stream regions near transcrip-
tion start sites. Thus, small RNAs from ncRNA termini are
likely to be produced by a different mechanism than that
used for TSSa-RNA and tiRNA generation, as well as
mRNA degradation.
Asymmetric processing of 50–30 terminal fragments
During miRNA biogenesis, each miRNA precursor is pro-
cessed to generate a small (22 nt) duplex, from which one
of the strands (miRNA) is preferentially incorporated into
Argonaute (AGO) and thus stabilized, while the other
strand, termed the passenger strand is often degraded
(31,32). Since the 50 and 30 ends of both tRNAs (33) and
many snoRNAs (28) form RNA duplexes, we speculated
that the terminal RNAs may be generated asymmetrically
from the 50 and 30 ends of the duplex. To explore this
possibility, for each tRNA, we compared the number of
50 terminal RNAs to that of 30 terminal RNAs. Among
the 447 tRNA genes that match terminal tRFs, 335 (75%)
tRNAs match both 50 and 30 terminal tRFs. Remarkably,
93% of these (313/335) tRNAs manifest considerable (2)
difference between their 50 and 30 tRF levels, while nearly
half of them (161) yield a difference of 10. To ensure that
these biases are not due to tRNAs that are similar in their
sequences, we reanalyzed our data using a non-redundant
set of 99 tRNAs that shared <90% sequence identity to
reconﬁrm the observed biases (Figure 3A). To further
conﬁrm that the biases are not limited to our BCP1 library
and to rule out protocol-based artifacts, we also analyzed
the results from an independent library from HEK293 cells
(34). We found similar patterns that were additionally con-
ﬁrmed using northern blots for four tRFs derived from two
different tRNAs (Supplementary Figure S2). These results
support the notion that tRNAs are generally processed into
two terminal tRFs but only one fragment is preferentially
maintained in cells, reminiscent of miRNAmaturation. The
bias is stronger for snoRNAs and snRNAs; the 95% (66/69)
snoRNAs generate terminal RNAs primarily from either
the 50 or 30 ends (Figure 3B), while all terminal snRNA frag-
ments are exclusively derived from 30 ends (Figure 2).
Terminal RNAs of rRNAs also seem to manifest a general
preference toward 30 terminal (Figure 3C). Since 50 and
30 ends of rRNAs likely do not form intra-molecular base
pairs to form a double-stranded structure within the
molecule (35), the asymmetry in ncRNA terminal RNAs
could be due to stabilization of the 50 or 30 fragment that
is cleaved off by the processing machinery.
We next sought to ﬁnd out whether the terminal RNAs
and their asymmetric processing bias are characteristics
that are evolutionarily conserved. Analysis of small RNA
libraries (36) from mouse embryonic stem cells (mESCs)
revealed that mESCs contain very abundant terminal
RNAs derived precisely from the 50 and 30 ends of
tRNAs (Figure 4A) that also manifest asymmetry in pro-
cessing (Figure 4B). Similar to human terminal tRFs,
termini-speciﬁc processing (Supplementary Figure S3)
and asymmetric stabilization (Supplementary Figure S4)
are also observed for mouse rRNAs, snoRNAs and
snRNAs. Furthermore, comparison of the asymmetric
processing bias of individual human tRNAs and their
putative mouse orthologs reveal a modest conservation
in their processing bias in generating terminal
tRFs (Supplementary Figure S5). Intriguingly, the process-
ing biases of 2030nt long tRFs are more cor-
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Figure 2. Small terminal RNA fragments are produced preferentially from 50 and 30 termini of rRNAs, snoRNAs, snRNA, but not mRNAs. Reads
(violet) that map to rRNA, snoRNAs, snRNAs and mRNAs are depicted as in Figure 1; positions are with respect to either the 50 end (left panel) or
the 30 end (right panel) of the RNAs (blue) as illustrated. Subpanels with the characteristic 50 or 30 preferences are highlighted (asterisk) for clarity.
For instance, snRNAs yield terminal RNAs exclusively from their 30 end (right panel).
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the 15 - to 19-nt-long tRFs. Taken together, these data
suggest that the mechanism to generate terminal RNAs
from various ncRNAs is a conserved process between
human and mice.
Terminal small RNAs are primarily independent
of Dicer and DGCR8
Since a few Dicer-dependent RNA products from tRNAs
(8) and snoRNAs (3) are known, we investigated whether
terminal RNAs are commonly processed through the
canonical miRNA pathway. Unlike other studies (4,36)
that normalized the data sets using RNAs derived from
tRNAs and snoRNAs, we used mRNA-derived fragments
for normalization. We used a normalization strategy (see
‘Materials and Methods’ section) based on mRNA frag-
ments because of our ﬁnding that mRNAs but not tRNAs
and snoRNAs, produce fragments that largely resemble
random degradation. Since the dependence of shorter
tRFs (15 nt) on Dicer/DGCR8 has not been investigated
yet, we separately analyzed the terminal RNAs of the two
different size groups (2030 and 1519 nt). As a class,
each terminal small RNA group manifest statistically
insigniﬁcant (P> 0.05) changes after either dicer 1
or dgcr 8 knockouts (Supplementary Figure S6A).
However, it is important to note that speciﬁc RNAs
within tRNAs, snoRNAs and snRNAs do manifest con-
siderable (>2-fold) difference in both Dicer and DGCR8
knockdowns (Supplementary Figure S6B). We next tested
whether the observed asymmetric processing of 50 and
30 tRFs is maintained during Dicer/DGCR8 deletions.
To compare asymmetric processing across different
samples, the processing bias was evaluated in each
library and for the 2030 and 1519 nt size groups
(Figure 4C). Consistent with the notion that these RNAs
are largely independent of the RNAi pathway, the
asymmetry proﬁles within each group are constant
across wild-type and dicer 1/dgcr8 knockout mES cells,
yielding Pearson correlation coefﬁcients (r) in the range
of 0.89–0.97.
Presence of endogenous Ago2-associated 30 tRFs
that are capable of cleaving target RNAs
To further investigate processing and function of tRF, we



















































Figure 3. Terminal small RNA fragments from tRNAs, snoRNAs and rRNAs manifest a bias for either 50 or 30 processing. (A) Abundance of 50
(solid blue) and 30 (blue) terminal RNAs produced from individual tRNAs (X-axis). For clarity, illustration is limited to non-redundant tRNA
sequences producing at least 10 reads (per million) of terminal RNAs. Similar patterns are observed for snoRNAs (B) and rRNAs (C). Proﬁles of
snRNAs are omitted because they yield terminal RNAs exclusively from their 30 end (Figure 2).
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in vitro studies (Figure 5). We ﬁrst analyzed possible Dicer
requirements for their biogenesis (Figure 5A). Total RNA
fromwild-type (Dicer+/+) andDicer knock out (Dicer/)
mouse embryonic ﬁbroblasts (MEFs) was used for
Northern blotting using probes against the HisGTG
(Figure 5A, upper panel) and the LeuCAG fragment
(lower panel). Indeed, small RNA production from these
tRNAs is readily detectable in Dicer-deﬁcient cells,
indicating that these tRFs are independent ofDicer process-
ing. To probe into the possibility that some terminal RNAs
might use the RNAi pathway to inhibit target transcripts,
we further examined whether tRFs associate with Ago2.
Endogenous Ago2 was immunoprecipitated using
anti-Ago2 antibodies and co-immunoprecipitated RNA
was analyzed by Northern blotting using probes speciﬁc to
HisGTG and LeuCAG (Figure 5B). Both tRFs were
detected in anti-Ago2 immunoprecipitates demonstrating
that tRFs can be speciﬁcally loaded into Ago protein
complexes. Although previous studies have indicated that
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Figure 4. Processing of 50–30 terminal RNA fragments are conserved in mice. (A) Position of the small RNA reads relative to 50 (left panel) and
30 (right panel) termini of tRNAs. (B) Similar to human 50–30 terminal tRFs, the mouse tRFs preferentially yield either 50 or 30 fragments.
(C) Asymmetric bias of abundant (10 reads/million) 50 and 30 tRFs is well preserved across different conditions [wild-type, Dicer/DGCR8
Knock outs (KO)] for each tRNA, with high Pearson correlation coefﬁcients (0.890.97).
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it has not been shown yet whether tRFs can cleave target
RNAs. Indeed, based on the selection of high abundance of
reads in Ago2-associated data, northern blotting assays
conﬁrmed that 30 tRFs from two tRNAs are associated
with endogenous Ago2 (Figure 5B). Analysis using
Flag-HA-Ago2 complexes also reconﬁrmed the association
of these 30 tRFs with Ago2 (Figure 5C). Since Ago2, but not
Ago1 cleaves targetmRNA (37,38), we immunoprecipitated
Flag-HA-Ago1 and Flag-HA-Ago2 complexes from trans-
fected HEK293 cells using anti-Flag antibodies (Figure 5C)
and incubated them with a 32P-cap labeled artiﬁcial target
mRNA (100 nt) containing a region (17–18nt) fully com-
plementary to the endogenous 30 tRFs from the two differ-
ent tRNAs (LeuCAG and HisGTG). Both endogenous 30
tRFs directed Ago2-mediated cleavage. In contrast,
although both 30 tRFs are found in the Ago1 sequencing
library (3), the catalytically inactive Ago1 (38), does not
co-purify with any cleavage products. These results
suggest that 30 tRFs from tRNAs can function in an
RNAi-like pathway. Taken together with previous reports
using luciferase assays (6), our data support the notion that
tRFs have the potential to knock down target genes both at
RNA and protein levels.
ANG and other RNases can cleave tRNAs to produce
terminal tRFs
Since tRFs correspond to the most abundant and diverse
group of terminal RNAs and are independent of the ca-
nonical miRNA processors, we sought to understand their
biogenesis. To test potential candidate proteins involved
in the production of terminal tRFs, we focused on the
ANG nuclease (39), which generates 3050 nt long
sitRNAs from anti-codon loops during stress (12,18) and
was reported as a tRNA-speciﬁc enzyme (39,40). We
treated total RNA from 293 cells in vitro with recombinant
ANG and monitored the production of terminal RNA
fragments for tRNAs, rRNAs and snRNAs. At the
initial time point (0 h), endogenous small RNA species
are present in the absence of ANG treatment (Figure 6A
and Supplementary Figure S7). Expression of these en-



























































Figure 5. Presence of Ago2-associated 30 tRFs that can cleave target RNA. (A) Total RNA from Dicer knockout mouse cells (Dicer/) or
wild-type cells (Dicer+/+) were analyzed by northern blotting using probes speciﬁc for the 30 of tRNAs (HisGTG and LeuCAG), and miR-125 b.
(B) Endogenous Ago2 was immunoprecipitated from human HEK293 lysates, and the co-immunoprecipitated RNAs were extracted and analyzed by
northern blots using probes against the 30 tRFs (HisGTG and LeuCAG). GST antibody is used as control (C) Immunoprecipitated Flag-HA-Ago1
and Flag-HA-Ago2 were incubated with a 32P-cap-labeled target RNA (100 nt long), which contained a perfect complementary sequence to the
30 termini of tRNAs (HisGTG and LeuCAG). Lanes indicated with T1 represent RNaseT1 digestions of the RNA substrates as ladders. The RNA
sequence complementary to tRNA HIS-30 and tRNA LEU-30 is indicated by a black bar on the left.
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in a time-dependent manner, suggesting ANG is involved
in generating a variety of tRNA fragments, the sizes of
which correspond to previously reported 3050 nt
sitRNAs (12), as well as the 20 nt 50 (Supplementary
Figure S7) and 30 (Figure 6A) terminal RNAs reported
in our study. Processing of rRNA and snRNA, by ANG
seems to reﬂect random hydrolysis, resulting in a series of
RNA fragments (Supplementary Figure S8). Since ANG
belongs to the super family of RNase A (41), we examined
if RNase A produces terminal tRFs at low concentrations,
and tested the cleavage pattern of additional RNases. At a
much (30) lower concentration (0.3 mg/ml) of RNase A
than that was used for ANG, RNase was able to generate
both the 20 and 25 nt tRF bands speciﬁcally after 1-h
digestion (Figure 6B). Intriguingly, RNase I, a bacterial
RNase that can non-speciﬁcally digest all di-nucleotide
bonds (42), also generated similar tRFs at low concentra-
tions. In contrast, RNase T1, which cleaves only after
unpaired G residues (43), generates fragments that are
different than ANG, and RNase A/I (Figure 6B). These
observations indicate that multiple RNases expressed in a
given cell-type are likely responsible for the diverse range
of abundant terminal tRFs with varying lengths.
To further analyze the roles of different tRNA regions
on tRF production, we designed a series of mutations to
disrupt speciﬁc functional sub-structures of the tRNA and
monitored the tRNA cleavage patterns generated by ANG
(Figure 7 and Supplementary Figure S9). The mutations
were designed by an in silico screening of base substitu-
tions to yield candidates that preserve secondary struc-
tures outside the mutated domains. ANG cleavage of
wild-type tRNAs produced 20 nt long 30 terminal tRFs
(Figure 7A). Mutations that individually disrupt the
acceptor stem, the D stem, the anti-codon stem and the
TcC stem were ﬁrst examined (Supplementary Figure
S9AS9D). None of these mutations interfered with the
production of the terminal tRNA fragments by ANG after
in vitro cleavage of 0.5 h. Another mutation that com-
pletely altered the tRNA clover-leaf structure also did
not visibly affect tRF production (Supplementary Figure
S9E). However, three different mutants, each involving
point mutations around the ANG cleavage site on the
TcC loop, resulted in complete disappearance of the
terminal RNA bands (Figure 7C). Since the in vitro
transcribed tRNAs do not have modiﬁed nucleosides,
these results also indicate that post-transcriptional modi-
ﬁcations of tRNA are not a requirement for terminal
RNA processing. In summary, the major determinant in
processing of terminal small tRNAs by ANG and possibly























































(µg/ml) 0    0.01  0.3  10 0   0.01  0.3   10 0  0.01  0.3  10







Figure 6. Multiple RNases generate terminal tRFs from total RNA. (A) ANG (10 mg/ml) generates 20 nt long-terminal tRF as well as longer
sitRNAs from total RNA extracts. In comparison an equal concentration of RNase A completely degrades the RNA within an hour, while a control
lane with solution buffer (Buffer) generate terminal tRFs at much lower levels. (B) In vitro cleavage assay (t=1h) using total RNA from HEK293
cells (10 mg/lane) and different RNases at a series of concentrations indicate that at low concentrations, both RNase A and RNase I are able to
produce similar terminal tRFs as that of ANG (arrows). In contrast, RNase T1 generates a different set of 30 tRFs.
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Endogenous retroviral replication loci are preferentially
antisense to 30 terminal tRFs
The binding of tRNAs to retroviral primer binding sites
(PBS) facilitates the initiation of retroviral genome repli-
cation (44,45), such as that for the human immunodeﬁ-
ciency virus (HIV). Since endogenous human retroviral
sequences comprise 7% of the human genome (46), it
is possible that cells have evolved mechanisms to
regulate replication of these retroviral elements, particu-
larly for preventing accidental transcription of deleterious
retroviral sequences. We therefore investigated whether
the terminal tRFs have the potential to bind to human
endogenous retroviruses (HERVs). The majority of
HERVs exist in the human genome as long terminal
repeat (LTR) retrotransposons (47) which, together with
non-viral retrotransposons LINEs (long interspersed
nucleotide elements) and SINEs (small interspersed
nucleotide elements), form roughly 40% of the mamma-
lian genome (48). Terminal 30 tRFs are remarkably more
complementary to HERV LTRs than to LINEs and
SINEs (Figure 8A). Furthermore, even though the
number of distinct 30 and 50 BCP1 tRFs differ only by a
factor of two (1002 versus 507), 30 tRF sequences are
26-fold (2614 versus 100) more frequently complementary
to retrotransposon elements than the 50 tRFs; correspond-
ing to a normalized enrichment of 13-fold. Similarly,
30 tRFs are 4- to 6-fold more enriched (normalized) to
complementary sites in LINES and SINEs than 50 tRFs.
Analysis of the major LTR elements that are complemen-
tary to BCP1 tRFs (Figure 8B), indicate that the top
candidate tRF (LysTTT tRNA, 947 reads) is nearly iden-
tical to a known antisense DNA oligonucleotide that
targets the PBS region of HIV and can inhibit HIV repli-
cation (49). Moreover, the two 30 tRFs (LeuCAG and
HisGTG tRNAs) that we found to associate with Ago2
are also capable of degrading their target RNAs, and are
complementary to the ERVL-E and HERVH LTR
elements (Figure 5C).
DISCUSSION
We present here an in-depth study of terminal-speciﬁc
small RNAs from rRNAs, snRNAs, snoRNAs, tRNAs
and mRNAs that are generally missed in deep sequencing
studies because they are commonly ﬁltered out as poten-
tial degradation products during bioinformatics analysis.
While such strict ﬁltering greatly helps in focusing on the
most abundant and likely functional small RNA
molecules, emerging studies continue to provide evidence
that degradation-like products can have functional impact
and are abundant. Most importantly, whether these small
RNA products are functional or cellular noise, their study
continue to open up novel cellular mechanisms and inter-
esting cellular attributes (1–4,6–13,16,18,19,30,50–53).
Our own detailed analyses of small RNAs derived from
various classes of RNAs reveal novel, biologically import-
ant features for these small RNAs and support the notion
that terminal RNAs are not due to artifacts of cloning
methods used in deep sequencing methods. For clarity,
we note that the tRFs in this study are derived from
mature RNAs and do not include tRFs that could be
also processed from mature RNA precursors such as
that of pre-tRNAs (6,7). Comparisons across all novel
and other previously reported classes of tRNA/
snoRNA-derived RNAs, (3,4,6–8), indicate that the pro-
duction of terminal- and 50–30 end speciﬁc small RNAs,
are common features of constitutively expressed ncRNAs.
The distinct size distribution of terminal RNAs, as shown
by sequencing and northern blots, seem atypical for RNA
turnover products generated by common nuclear proof-
reading pathways, where mutant or defective RNAs are
degraded by nuclear exosomes (50,54), or by 50–30 exo-
nucleases Rat1 and Xrn1 (52). The extensive identiﬁcation
of both 50 and 30 terminal tRFs with similar size distribu-
tions in independent deep-sequencing studies that include
Ago bound small RNAs, suggests that tRFs exists due to a
yet unknown terminal-speciﬁc degradation mechanism or
by a processing mechanism that yields functional RNA























































































































Figure 7. ANG processes tRFs within the TcC loop. (A) ANG can process in vitro transcribed, synthetic tRNA (untreated/buffer/ANG incubations
at 0.5 h) to generate terminal tRFs. (B) Secondary structure of the in vitro-transcribed tRNA, highlighting the three mutations in TcC loop
(M1M3) and the tRF cleavage site (arrow). (C) ANG processing of the tRF is impaired by tRNA mutations in TcC loop (M1M3).
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present in mice indicative of a conserved terminal RNA
processing/degradation mechanism. While our in vitro
cleavage assay results suggest that various RNase
families including ANG are likely the factors that drive
tRF production, the association of these RNAs to AGO
as well as the dearth of mRNA-derived tRFs further seem
to support the notion that these RNAs could have a bio-
logical function, perhaps in a coordinated manner (55).
Why do ncRNAs but not mRNAs manifest terminal-
speciﬁc processing of small RNAs? Since mRNAs are
comprised of many constitutively expressed RNAs,
terminal RNA processing is unlikely to be a simple phe-
nomenon for all constitutively expressed RNAs, and
provides additional support to the notion that the phenom-
enon is independent of a random degradation process. We
also did not detect a preference for terminal small RNAs
among other well-known ncRNAs such as Y-RNAs (56).
One possibility is that terminal RNA processing might be a
hallmark of RNAs involved in fundamental and ancient
core processes such as translation. Consistent with the
notion of terminal RNAs as a process that evolved early,
we postulate that 30 tRFsmay have evolved as RNAi-based
modulators that block the replication of endogenous retro-
viral sequences (Figure 8C). Indeed, the RNAi pathway
evolved as an immune defense mechanism against viruses
in basal organisms that do not have protein-based adaptive
immune systems (57). While these concepts support the
view that terminal RNAs might be limited to core
ncRNAs as a pervasive phenomenon, we cannot yet rule
out that other classes of RNAs under various environmen-
tal conditions (e.g. stress) may also preferentially generate









































Viral replication Inhibition of Virus
Ago2?
C
LTR elements tRNA type tRF region  Copy of tRFs 
HERVK3 LysTTT GTCCCTGTTCGGGCGCCA 947 
HERVK14 LysCTT GCCCCACGTTGGGCGCCA 739 
HERV3 
ProAGG; 
ProTGG;ProCGG ATCCCGGACGAGCCCCCA 187 
Harlequin GluCTC;GluTTC TTCCCGGTCAGGGAACCA 174 
HERVL LeuTAA ACCCCACTCCTGGTACCA 173 
HERVK22 MetCAT TCCTCACACGGGGCACCA 170 
LTR25 GlyGCC;GlyCCC TTCCCGGCCAATGCACCA 160 
HERV9 ArgCCG GTCCCATCTGGGTCGCCA 157 
HERVH HisGTG ATCCGAGTCACGGCACCA 137 
MER51 ArgACG CTCCTGGCTGGCTCGCCA 116 
MER102a AsnGTT GCCCACCCAGGGACGCCA 113 
MSTB AspGTC TTCCCCGACGGGGAGCCA 106 
LTR49 SerCGA ATCCTGTTCGTGACGCCA 105 
HERVIP10FH IleAAT TCCCCGTACGGGCCACCA 63 
GACueLE-LVRE  ATCCCACTCCTGACACCA 63 
HERV9 ArgTCG GTCCCTTCGTGGTCGCCA 61 
MLT1H1 TyrGTA TTCCGGCTCGAAGGACCA 57 
ERVL IleTAT GCCTCACCTGGAGCACCA 33 
HERVK22 TrpCCA ATCACGTCGGGGTCACCA 27 
MLT1I ArgTCT GTCCCACCAGAGTCGCCA 25 
MSTB1 LeuAAG;LeuTAG ATCCCACCGCTGCCACCA 23 
MER57 LeuCAA ATCCCACTTCTGACACCA 22 
MLT1I AlaAGC TCCCCAGCATCTCCACCA 19 
MLT1G ArgCCT GTCCCACCTGGGGTACCA 11 
MER41E GlnCTG GTCTCGGTGGAACCTCCA 10 
B
Figure 8. 30 terminal tRFs might inhibit endogenous retroviral replication. (A) LTRs are highly enriched in complementary sequences of 30 terminal
tRFs. (B) The major tRNA terminal regions that produce abundant tRFs (reads 10, column 4) and their complementary LTR elements. (C) A
potential model for the 30 tRF pathway. The binding of 30 tRF to the transcribed viral RNA could recruit double-stranded RNA speciﬁc
endonucleases such as the highly efﬁcient Ago2, enabling the rapid cleavage of the transcribed endogenous viral RNA.
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Despite the prominent abundance of tRFs, their precise
functions remain unknown, yet several observations
suggest that the terminal tRFs may have a functional role
in the cell. The depletion of a tRF derived from a pre-tRNA
is known to increase cell proliferation and elevate the
number of cells in G2 phase of the cell cycle (7). Similarly,
the longer class of sitRNAs that are generated by ANG can
inhibit protein translation (12) to counteract stress, and
terminal tRFs likely have a similar function. Indeed, the
general role of small RNAs in stress response programs is
an emerging theme (58). Clearly, these observations
warrant mechanistic studies of the underlying pathways.
Our own observations that link 30 tRFs to HERVs
provide a testable hypothesis for a speciﬁc cellular role
for 30 terminal tRFs. It is conceivable that in normal cells
30 tRFs may be able to bind to the PBS region of human
endogenous retroviruses, blocking their replication though
endonuclease (e.g. AGO2) cleavage of the target transcript.
Indeed, we found that 30 tRFs are endogenously associated
with Ago2 and are able to guide Ago2 to cleave the target
RNA. Detailed experimental testing of this hypothesis
could take several years of research not only because of
the complexity of the regulation but also the difﬁculty in
working with endogenous viral products. It also remains
difﬁcult to study these RNAs because common
technologies such as RT-PCR are either not reliable or la-
borious (e.g. northern blot) for detecting these RNAs. Our
own studies would have been considerably more difﬁcult
than if we did not use recently developed northern blot
protocols (22) to routinely assay for the expression of
these small RNAs. It is likely that emerging third gener-
ation sequencing technologies and other microﬂuidic
technologies, combined with multiplexing, will provide
methods for cheaper and more robust detection of these
difﬁcult-to-study small RNAs that are typically smaller
than even miRNAs (59).
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online:
Supplementary Figures 1–9.
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